The 20 Best Diabetic Retinopathy Doctors Near Me in Ypsilanti, MI

Thomas Gardner is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Gardner is rated as an Elite provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Diabetic Macular Edema (DME), Vitrectomy, and Cataract Removal.

Ashvani Dass is an Ophthalmologist practicing medicine in Ypsilanti, Michigan. He has been practicing medicine for over 36 years. Dr. Dass is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Retinal Detachment, Late-Onset Retinal Degeneration, and Diabetic Retinopathy. Dr. Dass is board certified in American Board Of Ophthalmology. Dr. Dass is currently accepting new patients.

Harjeet Kaur is an Ophthalmologist practicing medicine in Ypsilanti, Michigan. She has been practicing medicine for over 44 years. Dr. Kaur is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Meibomianitis, Cataract, Blepharitis, and Glaucoma.

Anita Repp is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Repp is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Osteoporosis, Postmenopausal Osteoporosis, and Type 2 Diabetes (T2D).

Anuradha Puttagunta is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Puttagunta is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Thyroid Nodule, and Hypothyroidism.

Grant M. Comer, M.D., specializes in diseases and surgery of the retina and vitreous, including diagnosis and treatment of ocular melanoma retinal detachments, diabetic retinopathy, age-related macular degeneration (AMD), retinal vascular disease, ocular trauma, infectious chorioretinitis, and surgical management of complex retinal detachments.His research interests range from developing alternative treatment regimens for retinal diseases, including AMD and endophthalmitis, to studying the cost-effectiveness of vitreoretinal care and maximizing patient satisfaction through multimedia-based patient education.Dr. Comer received his medical degree from Indiana University in 2001. Following an internship at Methodist Hospital in Indianapolis, he completed a residency in ophthalmology at IU in 2005. From 205 to 2007 he undertook a vitreoretinal, uveitis and ocular oncology fellowship at the University of Michigan Kellogg Eye Center, and served as a clinical lecturer in the Department of Ophthalmology and visual Sciences from 2005 to 2009. In 2009, he earned a Master of Science in clinical research design and statistical analysis from the University of Michigan’s School of Public Health. His bibliography reflects 12 peer-reviewed papers, two book chapters, and several abstracts, as well as educational materials for patients. Dr. Comer is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, Vitrectomy, and Cataract Removal. Dr. Comer is board certified in Ophthalmology.

Dr. Shah earned her medical degree from the University of Michigan Medical School in 2006 and completed her residency in ophthalmology at the Cullen Eye Institute, Baylor College of Medicine in 2010. She was a medical retina fellow at New England Eye Center, Tufts University School of Medicine, followed by 2 years in private practice in the Boston area before joining the faculty at W.K. Kellogg Eye Center in 2013. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Diabetic Retinopathy, Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD). Dr. Shah is board certified in Ophthalmology.

David N. Zacks completed his undergraduate degree at Cornell University, where he majored in neurobiology. This was followed by a combined M.D. and Ph.D. from the Albert Einstein College of Medicine in Bronx, New York. He finished his ophthalmology residency in 2000 and his vitreo-retinal fellowship in 2002, both at the Massachusetts Eye and Ear Infirmary in Boston, Massachusetts. Dr. Zacks joined the Retina Service of the University of Michigan’s Kellogg Eye Center in 2002. His clinical activity focuses on diseases and surgery of the retina. His main research interest is in the molecular control of photoreceptor cell death during retinal disease. He holds (or has held) research grants from the National Eye Institute, Research to Prevent Blindness, Inc., Foundation Fighting Blindness, Midwest Eye Bank and Transplantation Center, as well as other foundations. Dr. Zacks has received numerous honors and is a member of various societies, including the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, the Retina Society, the Macula Society and the American Society of Retina Specialists. Dr. Zacks is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, and Vitrectomy. Dr. Zacks is board certified in Ophthalmology.

Rajesh Rao is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Rao is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Gyrate Atrophy of the Choroid and Retina. Dr. Rao is board certified in Ophthalmology.

Joshua Stein is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Stein is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Pigment-Dispersion Syndrome, Ocular Hypertension (OHT), Trabeculectomy, and Cataract Removal.

Michael Huvard, MD, is a ClinicalAssistant Professor in the Departments of Ophthalmology & VisualSciences. He earned his undergraduate degree in Philosophyat Northwestern University, where he graduated summa cum laude andwas inducted into Phi Beta Kappa. He then completed a post-baccalaureateresearch fellowship at the National Institutes of Health. He earned his medicaldegree from the University of Illinois Chicago College of Medicine, wherehe was inducted into the Alpha Omega Alpha medical honor society. Followingmedical school, he completed his ophthalmology residency at the Universityof Michigan Kellogg Eye Center. During residency he was awarded the2018 Walter R. Parker Resident Teaching Award. He subsequently completeda 2-year fellowship in Vitreoretinal Diseases and Surgery at theUniversity of Colorado Sue Anschutz-Rodgers Eye Center. He is now on faculty atthe University of Michigan Kellogg Eye Center, where he is dedicated toproviding outstanding patient care and training the next generation ofophthalmologists. The focus of his research is better definingthe clinical outcomes of diseases and surgery of the retina and vitreous,such as retinal detachments and posterior segment infectious and inflammatorydisorders, and improving medical and surgical education for medical trainees. Dr. Huvard is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Diabetic Retinopathy, Endophthalmitis, Late-Onset Retinal Degeneration, and Vitrectomy. Dr. Huvard is board certified in Ophthalmology.

Doctor Jennifer Wyckoff is a Clinical Professor of Internal Medicine in the Metabolism, Endocrinology and Diabetes/Podiatry Division. She received her MD degree from the University of South Florida in 1992 and completed her Internal Medicine Residency at the University of Utah in 1995. In addition, Dr. Wyckoff completed a fellowship in Endocrinology at the Brigham and Women's Hospital, Harvard Medical School, in 1999. Following that, she joined the faculty of the Joslin Diabetes Center, Harvard Medical School. While there, she practiced as part of the multidisciplinary Diabetes and Pregnancy program, a joint venture between the Joslin Diabetes Center and the Beth Israel Deaconess Hospital.In 2006, she joined the faculty at University of Michigan. Dr. Wyckoff serves as the Associate Clinical Chief for the Metabolism, Endocrinology and Diabetes/Podiatry Division and the Medical Director of the Adult Diabetes Education. Her clinical interests center on diabetes, with specific emphasis on diabetes and pregnancy, Type 1 diabetes and technology, patient education and cystic fibrosis related diabetes. Dr. Wyckoff is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Secondary Immunodeficiency (SID), and Gestational Diabetes. Dr. Wyckoff is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

William H. Herman is the Stefan S. Fajans/GlaxoSmithKline Professor of Diabetes, Professor of Internal Medicine in the Division of Metabolism, Endocrinology, and Diabetes and Professor of Epidemiology in the School of Public Health. He completed his undergraduate degree at Yale University and received his medical degree from Boston University. He gained a Masters of Public Health (Epidemiology) from the University of Michigan. Professor Herman's interests include clinical diabetes and diabetes epidemiology, especially in the areas of surveillance, screening, treatment, cost-effective analysis, and health policy. He has authored more than 400 original research papers, reviews and textbook chapters and is U-M Principal Investigator for the Diabetes Control and Complications Trial (DCCT), Epidemiology of Diabetes Interventions and Complications (EDIC), Diabetes Prevention Program (DPP), Diabetes Prevention Program Outcomes Study (DPPOS), and The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Professor Herman received the American Diabetes Association's Kelly West Award for outstanding achievement in diabetes epidemiology in 2006 and the U-M Dean's Award for Clinical and Health Services Research in 2007. From 2018 to 2021, he chaired the National Clinical Care Commission, a federal advisory committee charged with advising the Congress how to leverage federal policies and programs to better prevent and control diabetes in the United States. He has been recognized by Best Doctors as a Best Doctor in America for more than 10 years. Dr. Herman is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), Diabetic Neuropathy, and Gastric Bypass. Dr. Herman is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Heidelbaugh received his medical degree from Upstate Medical University at Syracuse in 1996, and completed his Family Practice residency at St. Joseph's Hospital Health Center, also in Syracuse, New York, in 1999. He is board-certified by the American Board of Family Medicine. He is the Director for the Third Year Required Clerkship. Dr. Heidelbaugh is actively involved in teaching both medical students and residents at Ypsilanti Health Center, and attends on the Department of Family Medicine's inpatient adult medicine at the University of Michigan Hospital. His clinical interests include gastroesophageal reflux disease (GERD) and other disorders of the gastrointestinal system; preventive health screening for men, women and children of all ages; chronic disease management; men's health, dermatologic procedures, and prenatal care. Dr. Heidelbaugh's practice encompasses patients of all ages, with a wide spectrum of both medical and psychosocial disease states.Dr. Heidelbaugh has a joint appointment in Family Medicine and Urology. Dr. Heidelbaugh is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Irritable Bowel Syndrome (IBS), Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Hormone Replacement Therapy (HRT), and Endoscopy.

Dr. Wong earned her medical degree from the University of Michigan Medical School (2004) and completed her residency training with the Department (2007), where she also served as co-chief resident, and completed an academic fellowship (2008). Prior to joining the Department, she was in private practice at Packard Health in Ann Arbor, Mich. She sees patients at Ypsilanti Family Medicine. Dr. Wong is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. Her clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Bowenoid Papulosis, Familial Hypertension, and Intrauterine Device Insertion.

Dr. George-Nwogu graduated from the Medical School at University College Hospital, University of Ibadan, Nigeria (1989) and completed her residency at the New York Medical College at St. Joseph's Medical Center in Yonkers, New York (2002). She serves at the Ypsilanti Family Medicine Center, and her clinical interests include women's health, children's health, and performing office-based procedures such as colposcopies. Dr. George-Nwogu also practices on the Department's obstetrical service. Personal interests include reading and walking. Dr. George is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. Her clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Intrauterine Device Insertion.

Thomas Wubben is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Wubben is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Diabetic Retinopathy, Vitrectomy, and Cataract Removal. Dr. Wubben is board certified in Ophthalmology.

Jennifer Iyengar is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Iyengar is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Thyroid Nodule, Paget's Disease of Bone, and Type 2 Diabetes (T2D).

Jennifer Franzese is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Franzese is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Thyroid Nodule.

Dr. Lynn Ang is currently a Clinical Associate Professor in the Metabolism, Endocrinology, and Diabetes Division, Internal Medicine Department at University of Michigan. Dr. Ang is one of the principle attending physicians for the Diabetes Transition Program. Dr. Ang’s clinical and research interests are in the fields of implementing optimal management of inpatient and outpatient hyperglycemia, creating protocols for inpatient hospital guidelines, identifying biomarkers to predict the development or progression of diabetic complications, detecting the earliest stages of complications to prevent progression of diseases, and developing sensitive diagnostic methods/treatment for those complications. Dr. Ang also serves as a Co-Director of Hospital Intensive Insulin Program. Dr. Ang has been actively involving in teaching internal medicine and podiatry residents, endocrinology fellows, and medical students in both ambulatory and inpatient clinical settings. She was a recipient of Goran Sundkvist Young Investigators Award for Clinical Science 2022. Dr. Ang is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Neuropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Ang is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.